Novartis Investigative Site

Harbin 150081

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms, Breast

Studies at this site

• A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer — Completed